Ignite Creation Date:
2024-05-06 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03666832
Status:
UNKNOWN
Last Update Posted:
2022-06-15
First Post:
2018-09-10
Brief Title:
Multi-center Open-label Phase 1b Clinical Trial to Evaluate the Safety Tolerability and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel
Sponsor:
Joon Oh Park
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
2017-10-150
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Joon Oh Park
Lead Sponsor Class:
OTHER
Responsible Party:
Joon Oh Park
Responsible Party Title:
Samsung Medical Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None